{"filing":{"accession_number":"0001437749-26-027332","cik":"0000925741","ticker":"BCDA","company_name":"BioCardia, Inc.","form":"8-K","filing_date":"2026-08-12","report_date":"2026-08-12","primary_document":"bcda20260812_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/925741/000143774926027332/bcda20260812_8k.htm"},"events":[{"id":27266,"run_id":24837,"accession_number":"0001437749-26-027332","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"BioCardia issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, including condensed consolidated statements of operations and selected balance sheet data. The disclosure includes quarterly net loss, operating expenses, cash position, and per-share metrics—all hallmarks of an earnings release. Item 2.02 explicitly covers \"Results of Operations and Financial Condition,\" and the attached Exhibit 99.1 is the formal press release announcing Q2 2026 financial results.","company_name":"BioCardia, Inc.","ticker":"BCDA","filing_date":"2026-08-12","form":"8-K","submitted_at":null,"items":[{"id":28719,"accession_number":"0001437749-26-027332","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"BioCardia issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, including condensed consolidated statements of operations and selected balance sheet data. The disclosure includes quarterly net loss, operating expenses, cash position, and per-share metrics—all hallmarks of an earnings release. Item 2.02 explicitly covers \"Results of Operations and Financial Condition,\" and the attached Exhibit 99.1 is the formal press release announcing Q2 2026 financial results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T20:30:05.349378+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28719,"accession_number":"0001437749-26-027332","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"BioCardia issued a press release on August 12, 2026 announcing its financial results for the quarter ended June 30, 2026, including condensed consolidated statements of operations and selected balance sheet data. The disclosure includes quarterly net loss, operating expenses, cash position, and per-share metrics—all hallmarks of an earnings release. Item 2.02 explicitly covers \"Results of Operations and Financial Condition,\" and the attached Exhibit 99.1 is the formal press release announcing Q2 2026 financial results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-12T20:30:05.349378+00:00","company_name":"BioCardia, Inc.","ticker":"BCDA","filing_date":"2026-08-12"}]}